Lupus Erythematosus, Discoid
Also known as: Discoid Lupus Erythematosus (DLE) / Discoid Lupus Erythematosus / Discoid lupus erythematosis / Chronic cutaneous lupus erythematosus / Chronic discoid lupus erythematosus (disorder) / Lupus erythematosus discoid / Lupus erythematosus discoides / Lupus erythematosis discoid / Discoid lupus erythematosus (disorder) / Lupus erythematosus / Lupus erythematosus (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00443 | Betamethasone | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. |
| DB14669 | Betamethasone phosphate | A fast acting ester prodrug of a corticosteroid used to treat inflammatory conditions. |
| DB00297 | Bupivacaine | A local anesthetic used in a wide variety of superficial and invasive procedures. |
| DB00608 | Chloroquine | An antimalarial drug used to treat susceptible infections with P. vivax, P. malariae, P. ovale, and P. falciparum. It is also used for second line treatment for rheumatoid arthritis. |
| DB01234 | Dexamethasone | A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders. |
| DB00663 | Flumethasone | A corticosteroid used to treat contact dermatitis, atopic dermatitis, eczema, psoriasis, diaper rash, and other skin conditions. |
| DB00959 | Methylprednisolone | A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases. |
| DB00994 | Neomycin | An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body. |
| DB00936 | Salicylic acid | An acid used to treat acne, psoriasis, calluses, corns, keratosis pilaris, and warts. |
| DB00620 | Triamcinolone | A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02701 | Nicotinamide | 0 | Completed | 1 |
| DB08895 | Tofacitinib | 0 | Terminated | 1 |
| DB12943 | Milatuzumab | 1 | Completed | 1 |
| DB05676 | Apremilast | 1 / 2 | Completed | 1 |
| DB16391 | Daxdilimab | 2 | Recruiting | 1 |
| DB16133 | Delgocitinib | 2 | Terminated | 1 |
| DB16650 | Deucravacitinib | 2 | Recruiting | 1 |
| DB00005 | Etanercept | 2 | Completed | 1 |
| DB00005 | Etanercept | 2 | Unknown Status | 1 |
| DB13139 | Levosalbutamol | 2 | Completed | 2 |
| DB08877 | Ruxolitinib | 2 | Completed | 1 |
| DB08877 | Ruxolitinib | 2 | Not Yet Recruiting | 1 |
| DB09029 | Secukinumab | 2 | Withdrawn | 1 |
| DB01041 | Thalidomide | 2 | Completed | 1 |
| DB08879 | Belimumab | Not Available | Completed | 1 |
| DB00443 | Betamethasone | Not Available | Completed | 1 |
| DB00337 | Pimecrolimus | Not Available | Completed | 1 |
| DB00337 | Pimecrolimus | Not Available | Withdrawn | 1 |